Levosulpiride 25 mg Injection | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Levosulpiride 25 mg Injection
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Injection
Class: D2 Antagonist Prokinetic (Parenteral)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Levosulpiride 25 mg Injection Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Levosulpiride 25 mg Injection brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Levosulpiride 25 mg Injection is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Levosulpiride 25 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Severe nausea and vomiting
- Diabetic gastroparesis (acute)
- Post-operative nausea/vomiting
- Refractory functional dyspepsia
Mechanism of Action
Levosulpiride is the levo-enantiomer of sulpiride — selective D2 receptor antagonist with prokinetic and antipsychotic (low-dose) effects. Enhances upper GI motility, accelerates gastric emptying, increases LOS tone.
Dosage & Administration
- Adults: 25 mg IM once or twice daily.
Side Effects
- Hyperprolactinaemia (galactorrhoea, gynaecomastia, menstrual irregularity), extrapyramidal symptoms (rare at low dose), drowsiness.
Contraindications
- Prolactinoma, pheochromocytoma, epilepsy, severe Parkinson's, breast cancer history.
Storage
Protect from light. Store 2–25 °C.
PCD Pharma Franchise for Levosulpiride 25 mg Injection
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 5 x 2ml
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Levosulpiride 25 mg Injection — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Levosulpiride 25 mg Injection, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Levosulpiride 25 mg Injection?
Trumac Healthcare is a WHO-GMP certified manufacturer of Levosulpiride 25 mg Injection in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Levosulpiride 25 mg Injection available for PCD pharma franchise on monopoly basis?
Yes. We offer Levosulpiride 25 mg Injection for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Levosulpiride 25 mg Injection?
Available pack sizes include: 5 x 2ml.
What is the MRP / trade price for Levosulpiride 25 mg Injection?
MRPs range from ₹65 to ₹65 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Levosulpiride 25 mg Injection?